Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy - PubMed

Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy - PubMed

Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy

Zaid Bilgrami 1, Ameer Abutaleb 1, Kenechukwu Chudy-Onwugaje 1, Patricia Langenberg 1, Miguel Regueiro 2, David A Schwartz 3, J Kathleen Tracy 1, Leyla Ghazi 4, Seema A Patil 1, Sandra M Quezada 1, Katharine M Russman 1, Charlene C Quinn 1, Guruprasad Jambaulikar 5, Dawn B Beaulieu 3, Sara Horst 3, Raymond K Cross Jr 6

Affiliations 

• PMID: 30604373
 
• DOI: 10.1007/s10620-018-5433-5

Erratum in

• Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.

  Bilgrami Z, Abutaleb A, Chudy-Onwugaje K, Langenberg P, Regueiro M, Schwartz DA, Tracy JK, Ghazi L, Patil SA, Quezada SM, Russman KM, Quinn CC, Jambaulikar G, Beaulieu DB, Horst S, Cross RK Jr.Dig Dis Sci. 2020 Feb;65(2):668. doi: 10.1007/s10620-019-05953-4.PMID: 31792670

Abstract

Introduction: Limitations in inflammatory bowel disease (IBD) care necessitate greater patient activation and self-efficacy, measures associated with positive health outcomes.

Methods: We assessed change in patient activation and general self-efficacy from baseline to 12 months through our TELEmedicine for IBD trial, a multicenter, randomized controlled trial consisting of a web-based monitoring system that interacts with participants via text messaging. A total of 222 adults with IBD who had experienced an IBD flare within 2 years prior to the trial were randomized into either a control arm that received standard care (SC) or an intervention arm that completed self-testing through the TELE-IBD system every other week (EOW) or weekly (W).

Results: Changes in self-efficacy scores were not significantly different between control and experimental groups. Patient activation scores were significantly different between standard care and the TELE-IBD EOW group only (p = 0.03).

Conclusions: Use of remote monitoring did not improve self-efficacy or patient activation compared to routine care.

Keywords: Inflammatory bowel disease; Patient activation; Self-efficacy; Telemedicine.

Similar articles

• Remote Monitoring and Telemedicine in IBD: Are We There Yet?

  George LA, Cross RK.Curr Gastroenterol Rep. 2020 Feb 10;22(3):12. doi: 10.1007/s11894-020-0751-0.PMID: 32040650 Review.
• Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year.

  Abutaleb A, Buchwald A, Chudy-Onwugaje K, Langenberg P, Regueiro M, Schwartz DA, Tracy JK, Ghazi L, Patil SA, Quezada SM, Russman KM, Quinn CC, Jambaulikar G, Beaulieu DB, Horst S, Cross RK.Inflamm Bowel Dis. 2018 Sep 15;24(10):2191-2197. doi: 10.1093/ibd/izy149.PMID: 29788137 Free PMC article. Clinical Trial.
• A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).

  Cross RK, Langenberg P, Regueiro M, Schwartz DA, Tracy JK, Collins JF, Katz J, Ghazi L, Patil SA, Quezada SM, Beaulieu D, Horst SN, Russman K, Riaz M, Jambaulikar G, Sivasailam B, Quinn CC.Am J Gastroenterol. 2019 Mar;114(3):472-482. doi: 10.1038/s41395-018-0272-8.PMID: 30410041 Clinical Trial.
• Age Modifies the Association Between Depressive Symptoms and Adherence to Self-Testing With Telemedicine in Patients With Inflammatory Bowel Disease.

  Chudy-Onwugaje K, Abutaleb A, Buchwald A, Langenberg P, Regueiro M, Schwartz DA, Tracy JK, Ghazi L, Patil SA, Quezada S, Russman K, Horst S, Beaulieu D, Quinn C, Jambaulikar G, Cross RK.Inflamm Bowel Dis. 2018 Nov 29;24(12):2648-2654. doi: 10.1093/ibd/izy194.PMID: 29846623 Free PMC article. Clinical Trial.
• EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review.

  Jackson BD, Gray K, Knowles SR, De Cruz P.J Crohns Colitis. 2016 Sep;10(9):1103-21. doi: 10.1093/ecco-jcc/jjw059. Epub 2016 Feb 29.PMID: 26928960 Review.